Imactis® CT-Navigation™
At a glance
In healthcare today, the demand for minimally invasive, highly precise diagnostic and therapeutic procedures continues to rise, driven by an aging population, increased incidence of cancer and chronic disease, and the growing emphasis on safety and efficiency.
CT-guided interventions have emerged as a critical solution to meet this demand, offering outstanding visualization and real-time guidance for targeting small, deep, or anatomically complex lesions. As healthcare providers seek to improve outcomes, reduce complications, and optimize resource utilization, CT-guided navigation technologies are becoming indispensable tools in interventional radiology, oncology and beyond.
1.96M
$14.2B
82%
50%
Key benefits
A revolution in interventional radiology
In interventional radiology, the success of the percutaneous procedure depends on correct needle positioning. The Imactis system helps the radiologist place one or more needles with great accuracy, in less time and with fewer control scans.
Versatility
Fully compatible with any type of needle, from 25 gauge to 11 gauge, Imactis can be used for a wide variety of procedures.
Ease-of-use
Imactis has a user-friendly workflow that is easily learned through hands-on training.
Accuracy
Imactis enables you to find the ideal path to the target.
Safety
Imactis is designed for patient safety
Award winner
Vizient® innovative technology designated product
Disclaimer
*Not indicated for guidance in the head, neck and central nervous or central circulatory system (Heart included)
References
- P. Durand et al. (Plos One, 2017), CHU Grenoble Alpes (France)
- As measured internally by IMACTIS. Results may vary.
- Based on Imactis® CT-Navigation™ users response to internal interview. Results may vary.
- American Society of Clinical Oncology. https://www.asco.org/abstracts-presentations/ABSTRACT411342
- Patil, Rohan, Interventional Radiology Market Size, Share, and Trends 2025 to 2034, Precedence Research, 07 June 2024.
- Data source is based on IMV 2018 CT Market Outlook Report. © 2018 IMV, part of the Science and Medicine Group.
- C. Teriitehau, H. Rabeh, E. Pessis, Q. Sénéchal, F. Besse and M. Bravetti. (2020). Reduction of patient radiation dose during percutaneous CT vertebroplasty: Impact of a new computer-assisted navigation (CAN) system. (Volume 55, Number 1). Radioprotection. https://doi.org/10.1051/radiopro/2019049
- As each hospital is unique, results may vary. GE Healthcare does not guarantee the results identified herein.
- Dr. Barral is a paid consultant for GE HealthCare and was compensated for participation in this testimonial. The statements by Dr. Barral described here are based on his own opinions and on results that were achieved in his unique setting. Since there is no “typical” hospital/clinical setting and many variables exist, i.e., hospital size, case mix, staff expertise, etc., there can be no guarantee that others will achieve the same results.
- Dr. Cornelis is a paid consultant for GE HealthCare and was compensated for participation in this testimonial. The statements by Dr. Cornelis described here are based on his own opinions and on results that were achieved in his unique setting. Since there is no “typical” hospital/clinical setting and many variables exist, i.e., hospital size, case mix, staff expertise, etc., there can be no guarantee that others will achieve the same results.
- Dr. Filippiadis is a paid consultant for GE HealthCare and was compensated for participation in this testimonial. The statements by Dr. Filippiadis described here are based on his own opinions and on results that were achieved in his unique setting. Since there is no “typical” hospital/clinical setting and many variables exist, i.e., hospital size, case mix, staff expertise, etc., there can be no guarantee that others will achieve the same results.